A University of Michigan study has found that intensity-modulated radiotherapy (IMRT) appears to be overused in men with prostate cancer. The authors noted that despite uncertainty about its relative effectiveness, IMRT was rapidly adopted from 2001 to 2007. During early adoption (2001-2003), men with high-risk disease were more likely to receive IMRT.
Abstract: Health Affairs, April 2012.
